Aug 11, 2020
StrideBio Expands Leadership Team with Appointment of William Monteith as Chief Operating Officer
Apr 01, 2020
Unchained Labs jumps into gene therapy and vaccines with new AAV stability application!
Mar 10, 2020
PhRMA Report Shows Nearly 400 Cell and Gene Therapies in Development to Target a Broad Range of Diseases
Feb 24, 2020
Vigene Biosciences Awarded Patent for improvements in the packaging efficiency of recombinantly-modified adeno-associated virus (AAV)
Feb 04, 2020
Columbus Children's Foundation receives commitment to accelerate production of curative treatments for children with ultra-rare genetic diseases
Jan 29, 2020
REGENXBIO Announces Presentations at the 16th Annual WORLDSymposium(TM) 2020
Jan 13, 2020
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform
Nov 19, 2019
AskBio Receives "Best Venture Funding" Award from Southeast BIO
Sep 17, 2019
AskBio Acquires Assets from RoverMed BioSciences, Adds Nanotechnology Precision to Delivery of AAV Gene Therapeutics
Sep 04, 2019
REGENXBIO Announces Exclusive Worldwide Option and License Agreement with Clearside Biomedical for Evaluation of In-Office Delivery Platform for RGX-314
Aug 27, 2019
Viralgen Receives cGMP Certification from European Medicines Agency
Aug 22, 2019
AskBio Applauds Pfizer's Continuing Investments in Gene Therapy
Aug 13, 2019
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
Jul 30, 2019
REGENXBIO To Host Conference Call on August 7 to Discuss Second Quarter 2019 Financial Results and Recent Operational Highlights
Jul 24, 2019
REGENXBIO Expands Pipeline Using NAV Vectors to Deliver Therapeutic Antibodies for the Treatment of Hereditary Angioedema and Neurodegenerative Diseases
Jul 24, 2019
REGENXBIO and Neurimmune Announce Collaboration to Develop Vectorized Antibodies for the Treatment of Neurodegenerative Diseases
Jul 02, 2019
AskBio's Perspective on Pfizer's 1b Clinical Trial Results on Duchenne MD Gene Therapy
May 30, 2019
Newly Approved Spinal Muscular Atrophy Gene Therapy, Zolgensma®, Validates AskBio Gene Therapy Platform
May 24, 2019
REGENXBIO Announces First FDA Approval of a Gene Therapy Based on Its Proprietary NAV® Technology Platform
Apr 17, 2019
REGENXBIO Appoints Dr. Steve Pakola as Chief Medical Officer